Medesis Pharma S.A.
Clinical-stage biotech developing treatments using its AONYS® drug delivery platform.
ALMDP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010844464
- LEI:
- 969500C15M96P00UR648
- Country:
- France
- Address:
- AVENUE DU GOLF, 34670 BAILLARGUES
- Website:
- https://www.medesispharma.com/
- Sector:
- Manufacturing
Description
Medesis Pharma is a clinical-stage pharmaceutical biotechnology company focused on developing treatments for serious diseases using its proprietary AONYS® drug delivery platform. The AONYS® technology is a micro-emulsion designed for buccal (oral) administration, enabling the intracellular delivery of various therapeutic molecules, including metal ions, interfering RNAs, and peptides. A key feature of the platform is its ability to transport active ingredients across the blood-brain barrier, making it a promising approach for neurological disorders. The company's development pipeline addresses diseases with high unmet medical needs, including neurodegenerative conditions like Alzheimer's disease and therapies for individuals exposed to nuclear radiation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-13 17:45 |
MEDESIS PHARMA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | 260.7 KB | ||
| 2021-06-15 19:00 |
MEDESIS PHARMA : COMPTE-RENDU ASSEMBLÉE GÉNÉRALE MIXTE DU 15 JUIN 2021
|
French | 759.6 KB | ||
| 2021-06-03 08:00 |
MEDESIS PHARMA : le plan de développement de son candidat médicament pour le tr…
|
French | 97.3 KB | ||
| 2021-06-03 08:00 |
MEDESIS PHARMA: the development plan of its drug candidate for the treatment of…
|
English | 94.3 KB | ||
| 2021-05-28 18:00 |
MEDESIS PHARMA : Assemblée Générale Mixte du 15 juin 2021
|
French | 427.7 KB | ||
| 2021-05-07 08:47 |
MEDESIS PHARMA : INITIATION DE COUVERTURE ANALYSTE PAR INVEST SECURITIES
|
French | 277.1 KB | ||
| 2021-04-28 08:00 |
MEDESIS PHARMA : RAPPORT FINANCIER ANNUEL 2020
|
French | 1.6 MB | ||
| 2021-04-14 08:00 |
MEDESIS PHARMA : RÉSULTATS ANNUELS & PERSPECTIVES 2021
|
French | 177.3 KB | ||
| 2021-03-12 08:00 |
MEDESIS PHARMA : DESCRIPTIF DU PROGRAMME DE RACHAT D'ACTIONS ET MISE EN OEUVRE …
|
French | 601.8 KB | ||
| 2021-03-12 07:00 |
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS ET MISE EN OEUVRE D'UN CONTRAT DE L…
|
French | 601.8 KB | ||
| 2021-02-09 18:30 |
MEDESIS PHARMA LEVE 7,35 M€ SUITE AU TRES VIF SUCCES DE SON INTRODUCTION EN BOU…
|
French | 151.4 KB | ||
| 2021-01-26 10:30 |
MEDESIS PHARMA LANCE SON INTRODUCTION EN BOURSE SUR EURONEXT GROWTH PARIS®
|
French | 652.0 KB |
Automate Your Workflow. Get a real-time feed of all Medesis Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medesis Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medesis Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-16 | N/A | Other | Sell | 1,000 | 1,170.00 EUR |
| 2024-01-18 | N/A | Other | Sell | 800 | 669.60 EUR |
| 2023-07-21 | N/A | Other | Sell | 1,000 | 1,400.00 EUR |
| 2023-07-04 | N/A | Other | Sell | 5,000 | 7,100.00 EUR |
| 2023-05-23 | N/A | Other | Sell | 3,140 | 6,908.00 EUR |
Peer Companies
